To content To menu DBV Technologies The epicutaneous immunotherapy company OK fr DBV Technologies About us Scientific advisory board Board of directors Management Viaskin® Products Viaskin® Peanut Viaskin® Platform Viaskin® Milk Viaskin® Egg Epicutaneous Immunotherapy (EPIT®) Mechanism of Action Viaskin® Technology Viaskin® patch Electrospray Manufacturing Investor Relations Stock Information Events & Webcasts Corporate presentation SEC Filings Corporate Governance Overview Board Members Audit Committee Compensation Committee Investor FAQs AMF Regulated information Annual Reports & General Meeting News & Events Press Releases Corporate Videos Scientific Publications Gallery Scientific congresses News & Events Press Releases Scientific Publications Scientific congresses Corporate Videos Gallery Share on Facebook Share on Twitter Share on LinkedIn Share on Google+ Home News & Events Scientific Publications Scientific Publication 10 have been found Advanced search Years 2016 2015 2014 2013 2012 2011 2010 2009 Number of results per page 10 20 50 Search 07/04/2016 EAACI 2016 Wavrin S. et al. EPIT is Safe and Efficacious in Filaggrin Deficient Mice Sensitized to Peanut Download (636KB) 07/04/2016 EAACI 2016 Zebina M. Development and validation of a sandwich enzyme-linked immunosorbent assay (ELISA) for the quantification of Ara h6 in peanut flour, peanut extract, and patches for epicutaneous immunotherapy (EPIT) Download (922KB) 07/04/2016 EAACI 2016 Peillon A. et al. Prediction of peanut-challenge outcome with biomarkers Download (640KB) 07/04/2016 EAACI 2016 Mondoulet L. et al. Unique epigenetic modulation by EPIT compared to OIT in a model of peanut sensitized mice: sustainable GATA-3 hypermethylation and Foxp3 hypomethylation Download (923KB) 07/04/2016 EAACI 2016 Mondoulet L. et al. Epicutaneous immunotherapy but not oral immunotherapy prevents eosinophilic infiltration in the esophagus in a model of milk sensitized mice Download (637KB) 07/04/2016 EAACI 2016 Mondoulet L. et al. EPIT-induced bystander effect mainly conferred by naïve Tregs via soluble factors and cell-cell contact in a murine model Download (639KB) 07/04/2016 EAACI 2016 Pascal I. et al. Characterization of peanut proteins on a patch for epicutaneous immunotherapy (EPIT) Download (651KB) 07/04/2016 EAACI 2016 Pelletier B. et al. EPIT-induced Tregs suppress T cell proliferation in specific and bystander conditions in a model of food allergen sensitized Download (930KB) 07/04/2016 EAACI 2016 Dioszeghy V. et al. Gut homing receptors designate epicutaneous immunotherapy as the most appropriate route for the treatment of food allergy in a model of peanut sensitized mice Download (918KB) 04/11/2016 Cellular & Molecular Immunology Dioszeghy V. et al Differences in Phenotype, homing properties and suppressive activities of Regulatory T cells induced by Epicutaneous, Oral or Sublingual Immunotherapy in Mice Sensitized to Peanut Download PDF (2.8MB) Follow us Follow us on Facebook Follow us on Twitter Follow us on LinkedIn RSS feed Share Share on Facebook Share on Twitter Share on LinkedIn Share on Google+ Contact DBV Technologies Office Headquarters 177-181 avenue Pierre Brossolette 92120 – Montrouge France Phone: +33 (0)1 55 42 78 78 Google Maps Contact form US Office 320 Park Avenue New York, NY 10022 United States Phone: +1-212-271-0863 Google Maps © DBV Technologies 2014 Credits Term of use Cookies Contact Site map Recruitments